Phase 1 first-in-human study of KSI-301: a novel anti-VEGF antibody biopolymer conjugate with extended durability

Patel, SS; Naor, J; Qudrat, A; Do, DV; Buetelspacher, D; Liang, H; Perlroth, DV

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019; 60 (9):